Stock ABEO ABEONA THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
3.19 USD +0.63% Intraday chart for Abeona Therapeutics Inc. -57.64% -36.33%
Apr. 23 Sector Update: Health Care Stocks Rise Late Afternoon MT
Apr. 23 Top Midday Decliners MT

Evolution of the average Target Price on Abeona Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

859a.Yz4Zl33Jf2ZZoRQ5H1kTbzac6SvKQVJW_SEJM_8DGQE.NHZUxxSHLlRrxUx4bxElCnfD0Vi_NDAkqmpwX4dEWFIkUnqmK_4aFyyMJA~8d5650d9773731ed23bb20682cf7154e

Analyst Recommendations on Abeona Therapeutics Inc.

Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $40 From $22, Maintains Overweight Rating MT
Alliance Global Starts Abeona Therapeutics at Buy With $20 Price Target MT
SVB Securities Adjusts Price Target on Abeona Therapeutics to $5 From $1, Maintains Market Perform Rating MT
Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $22 From $15, Reiterates Overweight Rating MT
SVB Leerink Downgrades Abeona Therapeutics to Market Perform From Outperform; Price Target is $1 MT
HC Wainwright Adjusts Abeona Therapeutics' Price Target to $4 From $5, Keeps Buy Rating MT
ABEONA THERAPEUTICS : HC Wainwright Adjusts Price Target on Abeona Therapeutics to $5 From $8, Maintains Buy Rating MT
ABEONA THERAPEUTICS : HC Wainwright Adjusts Abeona Therapeutics' Price Target to $8 From $11, Keeps at Buy MT
ABEONA THERAPEUTICS : B. Riley Adjusts Price Target on Abeona Therapeutics to $3 From $2, Reiterates Buy Rating MT
ABEONA THERAPEUTICS : Cantor Fitzgerald Upgrades Abeona Therapeutics to Overweight From Neutral; Price Target is $4 MT
ABEONA THERAPEUTICS : SVB Leerink Adjusts Abeona Therapeutics PT to $5 From $8, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.19 USD
Average target price
20.5 USD
Spread / Average Target
+542.63%
High Price Target
36 USD
Spread / Highest target
+1,028.53%
Low Price Target
12 USD
Spread / Lowest Target
+276.18%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Abeona Therapeutics Inc.

Cantor Fitzgerald
Alliance Global Partners
SVB Securities LLC
SVB Leerink
HC Wainwright

Ratings for Abeona Therapeutics Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ABEO Stock
  4. Consensus Abeona Therapeutics Inc.